Insmed Inc (INSM)

[smallinvestor]

i sound reasonable...but the current reality in the market isn't. The current 90 cents price on INSM is pricing almost a 50% chance of injunction, which i think is highly unlikely due to the test "in the interest of the public", especially for other indictions in the pipeline. It also prices in a possibility of stock dilution of probably 50 Million more shares at around $1.00 for 50 Million more cash, which lasts INSM another year or so. The best course for INSM, as I have discussed on many posts, is to sell to DNA for 3-4 bux, or find a EU partner soon. TRCA got a 80Million cash infusion from their partners as soon as they get MAA approval. (but they won't get it till probably July 2007)